Skip to main content

The Inflammatory Potential of Fibrin(ogen) and its Degradation Products

  • Chapter
Book cover Annual Update in Intensive Care and Emergency Medicine 2011

Part of the book series: Annual Update in Intensive Care and Emergency Medicine 2011 ((AUICEM,volume 1))

  • 2196 Accesses

Abstract

Coagulation is a constant attendant of inflammation and is fundamental to confine infection and/or the inflammatory response to a limited area. Coagulation is tightly controlled by various factors, such as tissue factor (TF), finally activating thrombin, which cleaves fibrinogen to initiate fibrin clot formation. Systemic inflammatory response syndrome (SIRS) and sepsis remain a major health concern on intensive care units (ICUs) in the western world often ending in multiple organ dysfunction and death. The pathogenesis of both systemic disorders are attributed to an uncontrolled inflammatory response and dysregulated coagulation, the latter often causing disseminated intravascular coagulation (DIC), microvascular failure and multiple organ dysfunction [1, 2]. Fibrin(ogen) degradation products, D-dimers, Bβ15-42 and soluble fibrin are increased in septic patients with organ dysfunction [3, 4], but the contribution of these fragments to the pathogenesis of sepsis remains unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86: 1327–1330

    PubMed  CAS  Google Scholar 

  2. Levi M, Ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341: 586–592

    Article  PubMed  CAS  Google Scholar 

  3. Iba T, Kidokoro A, Fukunaga M, et al (2005) Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers. Shock 23: 25–29

    Article  PubMed  CAS  Google Scholar 

  4. Fareed J, Hoppensteadt DA, Leya F, et al (1998) Useful laboratory tests for studying throm-bogenesis in acute cardiac syndromes. Clin Chem 44: 1845–1853

    PubMed  CAS  Google Scholar 

  5. Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109: 2698–2704

    Article  PubMed  Google Scholar 

  6. Medcalf RL (2007) Fibrinolysis, inflammation, and regulation of the plasminogen activating system. J Thromb Haemost 5 Suppl 1: 132–142

    Google Scholar 

  7. Knoebl P (2010) Blood coagulation disorders in septic patients. Wien Med Wochenschr 160: 129–138

    Article  PubMed  Google Scholar 

  8. Levi M (2010) The coagulant response in sepsis and inflammation. Hamostaseologie 30: 10–12, 14–16

    PubMed  CAS  Google Scholar 

  9. Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3: 1894–1904

    Article  PubMed  CAS  Google Scholar 

  10. Lord ST (2007) Fibrinogen and fibrin: scaffold proteins in hemostasis. Curr Opin Hematol 14: 236–241

    Article  PubMed  CAS  Google Scholar 

  11. Smith EB, Keen GA, Grant A, Stirk C (1990) Fate of fibrinogen in human arterial intima. Arteriosclerosis 10: 263–275

    PubMed  CAS  Google Scholar 

  12. Walker JB, Nesheim ME (1999) The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot per-fused with plasmin. J Biol Chem 274: 5201–5212

    Article  PubMed  CAS  Google Scholar 

  13. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11–25

    Article  PubMed  CAS  Google Scholar 

  14. Altieri DC (1999) Regulation of leukocyte-endothelium interaction by fibrinogen. Thromb Haemost 82: 781–786

    PubMed  CAS  Google Scholar 

  15. Ugarova TP, Yakubenko VP (2001) Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci 936: 368–385

    Article  PubMed  CAS  Google Scholar 

  16. Flick MJ, Du X, Degen JL (2004) Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo. Exp Biol Med (Maywood) 229: 1105–1110

    CAS  Google Scholar 

  17. Languino LR, Plescia J, Duperray A, et al (1993) Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73: 1423–1434

    Article  PubMed  CAS  Google Scholar 

  18. Harley SL, Sturge J, Powell JT (2000) Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. Arterioscler Thromb Vasc Biol 20: 652–658

    PubMed  CAS  Google Scholar 

  19. Lishko VK, Burke T, Ugarova T (2007) Antiadhesive effect of fibrinogen: a safeguard for thrombus stability. Blood 109: 1541–1549

    Article  PubMed  CAS  Google Scholar 

  20. Lishko VK, Yermolenko IS, Ugarova TP (2010) Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets. J Thromb Haemost 8: 799–807

    Article  PubMed  CAS  Google Scholar 

  21. Qi J, Goralnick S, Kreutzer DL (1997) Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells. Blood 90: 3595–3602

    PubMed  CAS  Google Scholar 

  22. Smiley ST, King JA, Hancock WW (2001) Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 167: 2887–2894

    PubMed  CAS  Google Scholar 

  23. Szaba FM, Smiley ST (2002) Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99: 1053–1059

    Article  PubMed  CAS  Google Scholar 

  24. Cunningham MA, Rondeau E, Chen X, et al (2000) Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191: 455–462

    Article  PubMed  CAS  Google Scholar 

  25. Senior RM, Skogen WF, Griffin GL, Wilner GD (1986) Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 77: 1014–1019

    Article  PubMed  CAS  Google Scholar 

  26. Persson K, Russell W, Morgelin M, Herwald H (2003) The conversion of fibrinogen to fibrin at the surface of curliated Escherichia coli bacteria leads to the generation of proinflammatory fibrinopeptides. J Biol Chem 278: 31884–31890

    Article  PubMed  CAS  Google Scholar 

  27. Hamaguchi M, Morishita Y, Takahashi I, et al (1991) FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. Blood 77: 94–100

    PubMed  CAS  Google Scholar 

  28. Robson SC, Shephard EG, Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86: 322–326

    Article  PubMed  CAS  Google Scholar 

  29. Lee ME, Rhee KJ, Nham SU (1999) Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages. Mol Cells 9: 7–13

    PubMed  CAS  Google Scholar 

  30. Lee ME, Kweon SM, Ha KS, Nham SU (2001) Fibrin stimulates microfilament reorganization and IL-1beta production in human monocytic THP-1 cells. Mol Cells 11: 13–20

    PubMed  CAS  Google Scholar 

  31. Olexa SA, Budzynski AZ, Doolittle RF, Cottrell BA, Greene TC (1981) Structure of fragment E species from human cross-linked fibrin. Biochemistry 20: 6139–6145

    Article  PubMed  CAS  Google Scholar 

  32. Vali Z, Scheraga HA (1988) Localization of the binding site on fibrin for the secondary binding site of thrombin. Biochemistry 27: 1956–1963

    Article  PubMed  CAS  Google Scholar 

  33. Bach TL, Barsigian C, Yaen CH, Martinez J (1998) Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. J Biol Chem 273: 30719–30728

    Article  PubMed  CAS  Google Scholar 

  34. Petzelbauer P, Zacharowski PA, Miyazaki Y, et al (2005) The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 11: 298–304

    Article  PubMed  CAS  Google Scholar 

  35. Atar D, Petzelbauer P, Schwitter J, et al (2009) Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 53: 720–729

    Article  PubMed  CAS  Google Scholar 

  36. Roesner JP, Petzelbauer P, Koch A, et al (2009) Bbeta15-42 (FX06) reduces pulmonary, myocardial, liver, and small intestine damage in a pig model of hemorrhagic shock and reperfusion. Crit Care Med 37: 598–605

    Article  PubMed  CAS  Google Scholar 

  37. Groger M, Pasteiner W, Ignatyev G, et al (2009) Peptide Bbeta(15–42) preserves endothelial barrier function in shock. PLoS One 4: e5391

    Article  PubMed  Google Scholar 

  38. Wiedemann D, Schneeberger S, Friedl P, et al (2010) The fibrin-derived peptide Bbeta(15–42) significantly attenuates ischemia-reperfusion injury in a cardiac transplant model. Transplantation 89: 824–829

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Jennewein, C., Tran, N., Zacharowski, K. (2011). The Inflammatory Potential of Fibrin(ogen) and its Degradation Products. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2011. Annual Update in Intensive Care and Emergency Medicine 2011, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18081-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18081-1_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-18080-4

  • Online ISBN: 978-3-642-18081-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics